Taylor Hoffman Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AWA
Taylor Hoffman Wealth Management's BMY Position: Q4 2022 in Review
Taylor Hoffman Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 7,373 shares — an estimated $524K sold.
Taylor Hoffman Wealth Management first reported a position in BMY in Q4 2017 and held it in 20 quarters. The position peaked at $654K in Q1 2018. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Taylor Hoffman Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- Taylor Hoffman Wealth Management sold 7,373 Bristol-Myers Squibb shares in Q4 2022, an estimated $524K.
- Taylor Hoffman Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 20 quarters.
- Taylor Hoffman Wealth Management's Bristol-Myers Squibb position peaked at $654K in Q1 2018.
- 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Taylor Hoffman Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.